261 related articles for article (PubMed ID: 11910068)
1. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies.
Briggs AH; O'Brien BJ; Blackhouse G
Annu Rev Public Health; 2002; 23():377-401. PubMed ID: 11910068
[TBL] [Abstract][Full Text] [Related]
2. Bayesian estimation of cost-effectiveness: an importance-sampling approach.
Heitjan DF; Li H
Health Econ; 2004 Feb; 13(2):191-8. PubMed ID: 14737756
[TBL] [Abstract][Full Text] [Related]
3. Bayesian estimation of cost-effectiveness from censored data.
Heitjan DF; Kim CY; Li H
Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
[TBL] [Abstract][Full Text] [Related]
4. Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies.
Zethraeus N; Johannesson M; Jönsson B; Löthgren M; Tambour M
Pharmacoeconomics; 2003; 21(1):39-48. PubMed ID: 12484802
[TBL] [Abstract][Full Text] [Related]
5. Using covariates to reduce uncertainty in the economic evaluation of clinical trial data.
Vázquez-Polo FJ; Negrín Hernández MA; López-Valcárcel BG
Health Econ; 2005 Jun; 14(6):545-57. PubMed ID: 15497202
[TBL] [Abstract][Full Text] [Related]
6. Incorporating model uncertainty in cost-effectiveness analysis: a Bayesian model averaging approach.
Negrín MA; Vázquez-Polo FJ
J Health Econ; 2008 Sep; 27(5):1250-9. PubMed ID: 18490067
[TBL] [Abstract][Full Text] [Related]
7. Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared.
Nixon RM; Wonderling D; Grieve RD
Health Econ; 2010 Mar; 19(3):316-33. PubMed ID: 19378353
[TBL] [Abstract][Full Text] [Related]
8. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials.
Doshi JA; Glick HA; Polsky D
Value Health; 2006; 9(5):334-40. PubMed ID: 16961551
[TBL] [Abstract][Full Text] [Related]
9. Design and analysis issues for economic analysis alongside clinical trials.
Marshall DA; Hux M
Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
[TBL] [Abstract][Full Text] [Related]
10. Bayesian cost-effectiveness analysis from clinical trial data.
O'Hagan A; Stevens JW; Montmartin J
Stat Med; 2001 Mar; 20(5):733-53. PubMed ID: 11241573
[TBL] [Abstract][Full Text] [Related]
11. Power and sample size calculations for stochastic cost-effectiveness analysis.
Briggs AH; Gray AM
Med Decis Making; 1998; 18(2 Suppl):S81-92. PubMed ID: 9566469
[TBL] [Abstract][Full Text] [Related]
12. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.
Willan AR; O'Brien BJ
Health Econ; 1996; 5(4):297-305. PubMed ID: 8880166
[TBL] [Abstract][Full Text] [Related]
13. A Bayesian approach to stochastic cost-effectiveness analysis.
Briggs AH
Health Econ; 1999 May; 8(3):257-61. PubMed ID: 10348420
[TBL] [Abstract][Full Text] [Related]
14. Handling uncertainty in economic evaluations of patient level data: a review of the use of Bayesian methods to inform health technology assessments.
McCarron CE; Pullenayegum EM; Marshall DA; Goeree R; Tarride JE
Int J Technol Assess Health Care; 2009 Oct; 25(4):546-54. PubMed ID: 19845985
[TBL] [Abstract][Full Text] [Related]
15. Design issues for conducting cost-effectiveness analyses alongside clinical trials.
Ramsey SD; McIntosh M; Sullivan SD
Annu Rev Public Health; 2001; 22():129-41. PubMed ID: 11274515
[TBL] [Abstract][Full Text] [Related]
16. A Bayesian model averaging approach for cost-effectiveness analyses.
Conigliani C; Tancredi A
Health Econ; 2009 Jul; 18(7):807-21. PubMed ID: 18792078
[TBL] [Abstract][Full Text] [Related]
17. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling.
Spiegelhalter DJ; Best NG
Stat Med; 2003 Dec; 22(23):3687-709. PubMed ID: 14652869
[TBL] [Abstract][Full Text] [Related]
18. A C++ program to calculate sample sizes for cost-effectiveness trials in a Bayesian framework.
Sarker SJ; Whitehead A; Khan I
Comput Methods Programs Biomed; 2013 Jun; 110(3):471-89. PubMed ID: 23399102
[TBL] [Abstract][Full Text] [Related]
19. An illustration of the modelling of cost and efficacy data from a clinical trial.
Hahn S; Whitehead A
Stat Med; 2003 Mar; 22(6):1009-24. PubMed ID: 12627415
[TBL] [Abstract][Full Text] [Related]
20. A Bayesian approach to stochastic cost-effectiveness analysis. An illustration and application to blood pressure control in type 2 diabetes.
Briggs AH
Int J Technol Assess Health Care; 2001; 17(1):69-82. PubMed ID: 11329846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
